ZIVALIO-M 500ER Tablets
For better Diabetic Outcomes
COMPOSITION – Zivalio-M 500 ER Dapagliflozin 10mg + Metformin HCL IP 500mg Tablets
>>Highly potent antihyperglycemic agent, beneficial for the treatment of type 2 diabetes (T2D).
>>Outstanding cardioprotective and renoprotective agent, an excellent option for patients with a history of cardiovascular and renal diseases.
>Monotherapy as well as combination therapy provides effective glycaemic control, and reduces body weight and blood pressure (BP) across a broad spectrum of patients.
>>Co-administration of dapagliflozin and metformin has a valuable synergistic effect in maintaining blood sugar levels and reduces the incidence of hypoglycemia.
>>Highly effective in both early and late stages of T2DM, this helps in stopping the clinical progression of diabetes mellitus.
Zivalio-M 500 ER Dapagliflozin 10mg + Metformin HCL IP 500mg Tablets
- Diabetes mellitus
- Cardiovascular disorders
- Renal diseases